Yongjian Liu Selected Research

vMIP-II

1/2021	CXCR4-Binding Positron Emission Tomography Tracers Link Monocyte Recruitment and Endothelial Injury in Murine Atherosclerosis.
1/2016	PET/CT Imaging of Chemokine Receptors in Inflammatory Atherosclerosis Using Targeted Nanoparticles.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yongjian Liu Research Topics

Disease

27	Neoplasms (Cancer) 07/2022 - 04/2012
14	Atherosclerosis 01/2021 - 01/2010
9	Inflammation (Inflammations) 07/2022 - 06/2013
5	Infections 01/2022 - 03/2013
5	Atherosclerotic Plaque (Atheroma) 01/2018 - 01/2010
4	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 02/2016
4	Fibrosis (Cirrhosis) 01/2022 - 01/2021
4	Poisoning 03/2021 - 04/2015
4	Disease Progression 01/2021 - 04/2014
4	Weight Gain 01/2018 - 01/2016
4	Vascular System Injuries 01/2017 - 07/2013
3	Hypoxia (Hypoxemia) 05/2020 - 10/2013
3	Glioma (Gliomas) 10/2018 - 09/2015
3	Catalepsy 02/2018 - 01/2016
3	Prostatic Neoplasms (Prostate Cancer) 11/2014 - 02/2013
2	Body Weight (Weight, Body) 07/2022 - 04/2020
2	Type 2 Diabetes Mellitus (MODY) 04/2022 - 03/2011
2	COVID-19 01/2022 - 01/2021
2	Carbon Monoxide Poisoning (Poisoning, Carbon Monoxide) 10/2021 - 09/2021
2	Myocardial Infarction 01/2021 - 01/2019
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021 - 05/2002
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2021 - 01/2012
2	Aneurysm (Aneurysms) 09/2020 - 09/2017
2	Rupture 03/2020 - 01/2020
2	Triple Negative Breast Neoplasms 01/2019 - 03/2016
2	Breast Neoplasms (Breast Cancer) 01/2018 - 01/2016
2	Orthostatic Hypotension (Postural Hypotension) 01/2018 - 01/2017
2	Lung Injury 02/2017 - 01/2017
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 02/2017 - 05/2016
2	Neointima 01/2017 - 01/2010
2	Neoplasm Metastasis (Metastasis) 04/2016 - 01/2016
1	Colorectal Neoplasms (Colorectal Cancer) 07/2022
1	Fatty Liver 06/2022
1	Non-alcoholic Fatty Liver Disease 06/2022
1	Fatigue 05/2022
1	Bites and Stings (Sting) 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Sepsis (Septicemia) 11/2021
1	Chemical and Drug Induced Liver Injury 10/2021

Drug/Important Bio-Agent (IBA)

11	Chemokine ReceptorsIBA 01/2021 - 07/2013
9	GoldIBA 01/2022 - 07/2012
9	Apolipoproteins E (ApoE)IBA 01/2021 - 07/2013
8	Pharmaceutical PreparationsIBA 01/2022 - 03/2013
8	Proteins (Proteins, Gene)FDA Link 10/2021 - 02/2016
8	Biomarkers (Surrogate Marker)IBA 10/2021 - 04/2014
7	Peptides (Polypeptides)IBA 05/2022 - 01/2015
6	ApolipoproteinsIBA 01/2021 - 07/2013
6	Natriuretic PeptidesIBA 05/2019 - 01/2010
4	CopperIBA 01/2021 - 01/2019
4	ChemokinesIBA 01/2021 - 07/2013
3	CC ChemokinesIBA 01/2021 - 03/2016
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 05/2002
3	AntibodiesIBA 01/2021 - 01/2015
3	Tumor Biomarkers (Tumor Markers)IBA 06/2019 - 04/2016
3	Atrial Natriuretic Factor (ANF)IBA 05/2019 - 01/2010
3	Phencyclidine (Angel Dust)IBA 02/2018 - 01/2016
3	ParaquatIBA 11/2017 - 04/2015
2	AntioxidantsIBA 07/2022 - 05/2020
2	LipidsIBA 06/2022 - 05/2022
2	Biological ProductsIBA 05/2022 - 02/2016
2	OligosaccharidesIBA 01/2022 - 01/2020
2	Acetaminophen (Paracetamol)FDA LinkGeneric 10/2021 - 01/2020
2	vMIP-IIIBA 01/2021 - 01/2016
2	CytokinesIBA 01/2021 - 01/2017
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2017
2	CCR5 Receptors (CCR5 Receptor)IBA 01/2021 - 04/2014
2	(64)Cu-DOTA-vMIP-IIIBA 01/2021 - 07/2013
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2020 - 05/2002
2	Lipopolysaccharide ReceptorsIBA 11/2017 - 01/2017
2	Histamine H1 Receptors (Histamine H1 Receptor)IBA 01/2017 - 01/2016
2	Messenger RNA (mRNA)IBA 01/2017 - 03/2011
2	Mechanistic Target of Rapamycin Complex 1IBA 05/2016 - 10/2013
2	Radioisotopes (Radionuclides)IBA 04/2016 - 01/2015
2	AmidesIBA 04/2016 - 03/2016
2	Monoclonal AntibodiesIBA 01/2016 - 10/2013
2	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2016 - 01/2010
1	lycoperoside HIBA 07/2022
1	hydrazine (hydrazine dihydrochloride)IBA 07/2022
1	Dimenhydrinate (DMH)FDA LinkGeneric 07/2022
1	oligochitosanIBA 06/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 05/2022
1	Liraglutide FDA Link 04/2022
1	Neuroprotective AgentsIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	CXC ChemokinesIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Collagen Type I (Type I Collagen)IBA 01/2022
1	rehmannia rootIBA 01/2022
1	InterferonsIBA 01/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 11/2021
1	HLA-DR Antigens (HLA-DR)IBA 11/2021
1	Ouabain (G Strophanthin)IBA 11/2021

Therapy/Procedure

15	Therapeutics 01/2022 - 01/2012
5	Precision Medicine 06/2019 - 04/2012
3	Drug Therapy (Chemotherapy) 01/2020 - 02/2017
2	Stents 09/2020 - 09/2017
2	Lung Transplantation 01/2018 - 01/2017
2	Transplantation 01/2018 - 01/2018
2	Highly Active Antiretroviral Therapy (HAART) 11/2015 - 01/2012
1	Liver Transplantation 10/2021